Atherosclerosis Plus
Elsevier Ireland Ltd · Ireland · Est. 2017
Aims & Scope✦ Inferred from recent articles
Atherosclerosis Plus publishes research on atherosclerosis and related cardiovascular diseases. The journal focuses on risk factors such as dyslipidemia, inflammation, and metabolic dysfunction, including the roles of lipoprotein(a), C-reactive protein-triglyceride-glucose index, and autoantibodies against apolipoprotein A-1. It also investigates cellular mechanisms, including vascular smooth muscle cell behavior, calcification, and the impact of extracellular vesicles and specific proteins like PCSK9 and G9A. Therapeutic interventions, including lipid-lowering drugs like bempedoic acid and statins, as well as diagnostic approaches and population-specific reference intervals, are also covered.
AI-summarised from recent articles · verify on publisher page →
General Information
Submission Info
Ethics & Quality
Think.Check.Submit Compliance
Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.
Publication & Citation Trend
Source: OpenAlex · Note: citations accumulate over time so older years appear higher
SJR Quartile by Discipline
Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.
Subject Classification
Web of Science Categories
Scopus Categories
Research Topics (OpenAlex)
You May Also Like
See all →Data updated: 2026-05-22 · Sources: SJR, DOAJ, OpenAlex, WoS, Crossref